Display options
Share it on

Korean J Thorac Cardiovasc Surg. 2013 Feb;46(1):1-13. doi: 10.5090/kjtcs.2013.46.1.1. Epub 2013 Feb 06.

The Anti-calcification Effect of Dithiobispropionimidate, Carbodiimide and Ultraviolet Irradiation Cross-linking Compared to Glutaraldehyde in Rabbit Implantation Models.

The Korean journal of thoracic and cardiovascular surgery

Samina Park, Soo Hwan Kim, Hong-Gook Lim, Cheong Lim, Yong Jin Kim

Affiliations

  1. Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Korea.

PMID: 23424053 PMCID: PMC3573159 DOI: 10.5090/kjtcs.2013.46.1.1

Abstract

BACKGROUND: Glutaraldehyde (GA) is a widely used cross-linking agent for improving mechanical properties and resistance to enzymatic degradation of collagenous tissue, but it has several drawbacks such as calcification and cytotoxicity. The aim of this study was to find the alternative effective cross-linking methods to GA.

MATERIALS AND METHODS: Bovine pericardium was processed with GA with ethanol+octanol and glycine detoxification, and polyethylene glycol (PG) space filler, dimethyl 3,3'-dithiobispropionimidate (DTBP), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) treatment, and the physical fixation of ultraviolet irradiation were done. The biologic material properties of variously treated pericardial tissues were assessed by biochemical, mechanical and histological tests. Treated pericardial tissues were also implanted subcutaneously or intramuscularly into the rabbit for 10 weeks to assess the xenoreactive antibody response of immunoglobulin G and M, their anti-calcification effect.

RESULTS: The biochemical and mechanical properties of EDC fixed pericardial tissues were comparable to the GA fixed tissue. The cytotoxicity was lowest in space filler treated GA fixed group. In rabbit subcutaneous or intramuscular implantation models, decellularization, space filler, EDC treatment group showed significantly lower calcium content than GA only and DTBP treatment group (p<0.05, analysis of variance). The titer of anti GalĪ±1-3GalĪ²1-4GlcNAc-R antibodies did not change in the postimplantation serial enzyme-linked immunosorbent assay. Hematoxylin and eosin and von Kossa staining showed that decellularization, space filler, EDC, and ultraviolet treatment had less inflammatory cell infiltration and calcium deposits.

CONCLUSION: The decellularization process, PG filler, and EDC treatments are good alternative cross-linking methods compared to GA only fixation and primary amine of DTBP treatment for cardiovascular xenograft preservation in terms of the collagen cross-linking stability and in vivo anti-calcification effects.

Keywords: Bioprosthesis; Glutaraldehyde; Pericardium; Polyethylene glycols; Ultraviolet

References

  1. J Heart Valve Dis. 1998 May;7(3):283-91 - PubMed
  2. J Heart Valve Dis. 1998 Mar;7(2):190-4 - PubMed
  3. Biomaterials. 2006 Mar;27(9):2123-30 - PubMed
  4. Eur J Cardiothorac Surg. 2011 Mar;39(3):381-7 - PubMed
  5. J Biomed Mater Res A. 2004 Apr 1;69(1):140-4 - PubMed
  6. Comp Med. 2009 Jun;59(3):266-71 - PubMed
  7. J Biomed Mater Res. 1994 Jun;28(6):655-66 - PubMed
  8. J Biomed Mater Res. 2000 Sep 5;51(3):343-51 - PubMed
  9. Interact Cardiovasc Thorac Surg. 2011 Jun;12(6):903-7 - PubMed
  10. Biomaterials. 2000 Nov;21(22):2215-31 - PubMed
  11. Biomaterials. 1994 May;15(6):465-9 - PubMed
  12. Biomaterials. 2005 Dec;26(35):7241-50 - PubMed
  13. J Biomed Mater Res. 2001 Jan;54(1):122-8 - PubMed
  14. J Biomed Mater Res. 1996 Oct;32(2):221-6 - PubMed
  15. Ann Thorac Surg. 2005 Mar;79(3):1072-80 - PubMed
  16. J Mater Sci Mater Med. 1999 Feb;10(2):121-8 - PubMed
  17. Biomaterials. 2011 Apr;32(12):3233-43 - PubMed
  18. Biomaterials. 1996 Apr;17(8):765-73 - PubMed
  19. J Biomed Mater Res. 1999 Dec 15;47(4):439-65 - PubMed
  20. J Biomed Mater Res. 1995 Nov;29(11):1373-9 - PubMed
  21. Circulation. 1997 Jan 21;95(2):479-88 - PubMed
  22. Biomaterials. 2004 Nov;25(24):5523-30 - PubMed

Publication Types